Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. RhoGDI-induced hypertrophic growth in H9c2 cells is negatively regulated by ZAK
 
  • Details
Options

RhoGDI-induced hypertrophic growth in H9c2 cells is negatively regulated by ZAK

Journal
Journal of Biomedical Science
Date Issued
2009-01-01
Author(s)
LI-CHIU YANG  
DOI
10.1186/1423-0127-16-11
URI
https://www.scopus.com/pages/publications/63449109564
https://scholars.csmu.edu.tw/handle/123456789/28776
Abstract
We found that overexpression of RhoGDI, a Rho GDP dissociation inhibitor, induced hypertrophic growth and suppressed cell cycle progression in a cultured cardiomyoblast cell line. Knockdown of RhoGDI expression by RNA interference blocked hypertrophic growth. We further demonstrated that RhoGDI physically interacts with ZAK and is phosphorylated by ZAK in vitro, and this phosphorylation negatively regulates RhoGDI functions. Moreover, the ZAK-RhoGDI interaction may maintain ZAK in an inactive hypophosphorylated form. These two proteins could negatively regulate one another such that ZAK suppresses RhoGDI functions through phosphorylation and RhoGDI counteracts the effects of ZAK by physical interaction. Knockdown of ZAK expression in ZAK- and RhoGDI-expressing cells by ZAK-specific RNA interference restored the full functions of RhoGDI.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback